{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:10:06Z","timestamp":1789531806696,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CAMS Initiative for Innovative Medicine","award":["2017-I2M-3-001"],"award-info":[{"award-number":["2017-I2M-3-001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771780, 81471615, 81102268, 81302610"],"award-info":[{"award-number":["81771780, 81471615, 81102268, 81302610"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Outstanding Youth Fund of Peking Union Medical College Hospital","award":["JQ201504"],"award-info":[{"award-number":["JQ201504"]}]},{"name":"2016 PUMCH Science Fund for Junior faculty","award":["pumch-2016-1.5"],"award-info":[{"award-number":["pumch-2016-1.5"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10067-019-04501-9","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T12:42:21Z","timestamp":1555504941000},"page":"2181-2187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis"],"prefix":"10.1007","volume":"38","author":[{"given":"Chaojun","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4541-9898","authenticated-orcid":false,"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"4501_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2010.1977","volume":"305","author":"LG Rider","year":"2011","unstructured":"Rider LG, Miller FW (2011) Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA 305:183\u2013190","journal-title":"JAMA"},{"key":"4501_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982","journal-title":"Lancet"},{"key":"4501_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-0034-1371528","volume":"35","author":"RW Hallowell","year":"2014","unstructured":"Hallowell RW, Ascherman DP, Danoff SK (2014) Pulmonary manifestations of polymyositis\/dermatomyositis. Semin Respir Crit Care Med 35:239\u2013248","journal-title":"Semin Respir Crit Care Med"},{"key":"4501_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/BOR.0b013e32833f1970","volume":"22","author":"A Labirua","year":"2010","unstructured":"Labirua A, Lundberg IE (2010) Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol 22:633\u2013638","journal-title":"Curr Opin Rheumatol"},{"key":"4501_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1378\/chest.96.1.68","volume":"96","author":"N Kohno","year":"1989","unstructured":"Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M (1989) New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 96:68\u201373","journal-title":"Chest"},{"key":"4501_CR6","first-page":"27","volume":"28","author":"F Bonella","year":"2011","unstructured":"Bonella F, Volpe A, Caramaschi P et al (2011) Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement. Sarcoidosis Vasc Diffuse Lung Dis 28:27\u201333","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"4501_CR7","first-page":"1112","volume":"31","author":"K Yanaba","year":"2004","unstructured":"Yanaba K, Hasegawa M, Takehara K, Sato S (2004) Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis. J Rheumatol 31:1112\u20131120","journal-title":"J Rheumatol"},{"key":"4501_CR8","first-page":"795","volume":"31","author":"R Vesely","year":"2004","unstructured":"Vesely R, Vargova V, Ravelli A et al (2004) Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis. J Rheumatol 31:795\u2013800","journal-title":"J Rheumatol"},{"key":"4501_CR9","first-page":"S","volume":"32","author":"G Kumanovics","year":"2014","unstructured":"Kumanovics G, Gorbe E, Minier T, Simon D, Berki T, Czirjak L (2014) Follow-up of serum KL-6 lung fibrosis biomarker levels in 173 patients with systemic sclerosis. Clin Exp Rheumatol 32:S\u2013138-144","journal-title":"Clin Exp Rheumatol"},{"key":"4501_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/ard.59.4.257","volume":"59","author":"S Bandoh","year":"2000","unstructured":"Bandoh S, Fujita J, Ohtsuki Y, Ueda Y, Hojo S, Tokuda M, Dobashi H, Kurata N, Yoshinouchi T, Kohno N, Takahara J (2000) Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis\/dermatomyositis. Ann Rheum Dis 59:257\u2013262","journal-title":"Ann Rheum Dis"},{"key":"4501_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"4501_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"key":"4501_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155381","volume":"11","author":"L Zhang","year":"2016","unstructured":"Zhang L, Wu G, Gao D, Liu G, Pan L, Ni L, Li Z, Wang Q (2016) Factors associated with interstitial lung disease in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. PLoS One 11:e0155381","journal-title":"PLoS One"},{"key":"4501_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1365-2796.2011.02459.x","volume":"271","author":"M Fathi","year":"2012","unstructured":"Fathi M, Barbasso Helmers S, Lundberg IE (2012) KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis. J Intern Med 271:589\u2013597","journal-title":"J Intern Med"},{"key":"4501_CR15","unstructured":"Wang Y, Chen S, Lin Z, du G, Lin J, Lin Q, Xiufeng H, Zhang G, Furst DE, Gargani L, Matucci-Cerinic M (2018) Imaging and serum biomarkers in connective tissue disease-associated interstitial lung diseases: correlation between lung ultrasound B-lines and KL-6 levels. Ann Rheum Dis:annrheumdis-2018-214098"},{"key":"4501_CR16","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3899\/jrheum.170518","volume":"45","author":"GA Salazar","year":"2018","unstructured":"Salazar GA, Kuwana M, Wu M, Estrada-Y-Martin RM, Ying J, Charles J, Mayes MD, Assassi S (2018) KL-6 but not CCL-18 is a predictor of early progression in systemic sclerosis-related interstitial lung disease. J Rheumatol 45:1153\u20131158","journal-title":"J Rheumatol"},{"key":"4501_CR17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00296-018-3987-3","volume":"38","author":"A Benyamine","year":"2018","unstructured":"Benyamine A, Heim X, Resseguier N, Bertin D, Gomez C, Ebbo M, Harl\u00e9 JR, Kaplanski G, Rossi P, Bardin N, Granel B (2018) Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Rheumatol Int 38:813\u2013819","journal-title":"Rheumatol Int"},{"key":"4501_CR18","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/BOR.0000000000000104","volume":"26","author":"RW Hallowell","year":"2014","unstructured":"Hallowell RW, Danoff SK (2014) Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances. Curr Opin Rheumatol 26:684\u2013689","journal-title":"Curr Opin Rheumatol"},{"key":"4501_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","volume":"11","author":"I Marie","year":"2012","unstructured":"Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Tiev KP, Vittecoq O, Noel D, Mouthon L, Menard JF, Jouen F (2012) Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11:739\u2013745","journal-title":"Autoimmun Rev"},{"key":"4501_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10067-015-3167-8","volume":"35","author":"EO Oguz","year":"2016","unstructured":"Oguz EO, Kucuksahin O, Turgay M, Yildizgoren MT, Ates A, Demir N, Kumbasar OO, Kinikli G, Duzgun N (2016) Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study. Clin Rheumatol 35:663\u2013666","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04501-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04501-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04501-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:19:23Z","timestamp":1584490763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04501-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4501"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04501-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"assertion":[{"value":"23 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Medical Ethics Committee of Peking Union Medical College Hospital (S-478). The methods were carried out in accordance with the principles stated in the Declaration of Helsinki, and informed consent was obtained from each patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}